The U.S. Department of Justice has significantly changed its approach to corporate criminal enforcement, increasingly choosing to resolve investigations without filing criminal charges against companies even in cases where prosecutors believed senior executives or managers were involved in misconduct.

The shift reflects a broader policy under the Trump administration that seeks to prioritize individual accountability while limiting the economic consequences that criminal prosecutions can impose on businesses.

Charging a corporation is among the Justice Department's most powerful enforcement tools.

A criminal conviction can trigger substantial fines, reputational damage, restrictions on government contracting and financing, and, in some cases, threaten the company's viability.

Supporters of the newer approach argue that those consequences often fall on shareholders, employees and customers rather than the executives responsible for misconduct.

Critics counter that reducing corporate prosecutions weakens deterrence and diminishes accountability for large organizations.

The policy shift has become visible through several high-profile resolutions.

Alibaba and its U.S.-based payment subsidiary entered non-prosecution agreements after admitting failures that allowed illegal pharmaceuticals, controlled substances, chemicals and pill presses to be sold through online platforms serving U.S. customers.

The companies agreed to pay hundreds of millions of dollars, implement compliance measures and cooperate with authorities, but criminal charges were not filed.

A similar outcome occurred in the case involving EagleBank.

Federal investigators concluded that the bank had knowingly permitted favored customers to engage in a long-running check-kiting scheme and had approved an unsound federally guaranteed loan while manipulating records to conceal payment problems.

Rather than pursuing criminal charges, prosecutors resolved the investigation through a non-prosecution agreement that included financial penalties, admissions of wrongdoing and commitments to strengthen anti-money-laundering controls.

Another example involved Abbott Laboratories.

Justice Department leadership decided to end a long-running criminal investigation into the company's handling of contaminated infant formula despite reported recommendations from some career prosecutors that criminal charges should be pursued.

The decision has been viewed by legal observers as another indication that department leadership has adopted a higher threshold for bringing criminal cases against corporations, particularly in matters involving consumer products and public health.

The administration maintains that these outcomes should not be interpreted as reduced enforcement.

Department officials argue that every resolution is based on the evidence and the law rather than a predetermined preference for avoiding corporate prosecutions.

They also emphasize that companies receiving favorable treatment are generally expected to cooperate with investigators, voluntarily disclose misconduct when appropriate, strengthen compliance systems and pay substantial financial penalties.

A department-wide corporate enforcement policy issued earlier this year formalized incentives for voluntary self-disclosure and cooperation while preserving prosecutors' authority to pursue criminal charges when aggravating circumstances warrant them.

A central element of the new strategy is the belief that prosecuting individuals provides a stronger deterrent than prosecuting organizations.

Senior Justice Department officials have repeatedly argued that corporations themselves cannot be imprisoned, whereas executives who knowingly commit crimes can face personal criminal liability.

The department has therefore stated that investigators should concentrate resources on identifying and prosecuting responsible individuals whenever the available evidence supports doing so.

Some former prosecutors and white-collar defense specialists acknowledge that the approach reduces uncertainty for businesses and encourages cooperation with investigators.

Others question whether the policy is achieving its stated objective.

They note that several recent corporate resolutions concluded without criminal charges against either the companies or individual executives, prompting concerns that both forms of accountability may be declining simultaneously rather than one replacing the other.

The debate extends beyond individual cases because it affects how corporations evaluate legal risk.

If companies perceive that voluntary cooperation is more likely to result in negotiated settlements than criminal convictions, they may have stronger incentives to self-report violations and improve internal compliance.

Conversely, if the perceived likelihood of criminal prosecution falls too far, critics argue that some organizations may conclude that financial settlements represent a manageable cost of doing business.

The long-term consequences of the policy shift will likely be measured not by the number of corporate indictments but by broader indicators, including rates of voluntary disclosure, successful prosecutions of individual executives, corporate compliance improvements and future levels of financial and consumer-protection misconduct.

For now, what is confirmed is that the Justice Department has adopted a markedly different balance between corporate punishment and negotiated resolution, making criminal charges against companies less common while continuing to rely heavily on settlements, compliance obligations and financial penalties.